The Lancet. MicrobeHumansVirus SheddingAntiviral AgentsSARS-CoV-2Male
SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies.
Melisa M Shah, Glen R Abedi, Scott Lu, Miguel Garcia-Knight, Jesus Pineda-Ramirez, Sarah A Goldberg, Carlos G Grijalva, H Keipp Talbot, Jonathan Schmitz, Karen Lutrick, Katherine D Ellingson, Melissa S Stockwell, Ellen Sano, Huong Q Nguyen, Suchitra Rao
Published: 202610.1016/j.lanmic.2025.101227
Abstract
BACKGROUND: The effect of COVID-19 oral antivirals on the duration of SARS-CoV-2 infectious viral shedding and viral rebound remains uncertain. This study aimed to examine the association of oral antivirals with viral dynamics, shedding of infectious…
Preview only. Read the full abstract at the source